Nascent Biotech Inc
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6330 Nancy Ridge Dr Ste 105, San Diego, ...Phone Number
(612) 961-5656Website
www.nascentbiotech.comRevenue
<$5 MillionStock Symbol
NBIOIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nascent Biotech Inc
Nascent Biotech specializes in developing human antibody products for cancer treatment, notably their proprietary monoclonal antibody Pritimumab, which targets a novel antigen on cancer cells. The company has achieved FDA orphan drug status for Pritimumab, demonstrating its commitment to addressing rare forms of cancer. Their product line also includes CLNH5 and MultiPharm, aimed at enhancing cancer therapies. Nascent Biotech primarily serves patients with rare cancers and seeks to advance its research through pivotal clinical trials.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nascent Biotech Inc your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Nascent Biotech Inc is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Nascent Biotech Inc
Earning: See what the market has to say on Nascent Biotech Inc recently announced quarterly report
Nascent Biotech Inc, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Nascent Biotech Inc had a recent Job posting/layoffs
Product Launch: Get notified when Nascent Biotech Inc launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Nascent Biotech Inc has new funding data
Check if Nascent Biotech Inc has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nascent Biotech Inc
Compare insights from companies similar to Nascent Biotech Inc, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nascent Biotech Inc
<$5M
1-10
Public
<$5M
2014
N/A
Company Profile Activity
Activity Insights
Nascent Biotech Inc is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nascent Biotech Inc is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nascent Biotech Inc.
Nascent Biotech Inc financials insights
Gather financial insights about Nascent Biotech Inc, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$740K
Nascent Biotech Inc Tech Stack
A closer look at the technologies used by Nascent Biotech Inc
See more technologies
Nascent Biotech Inc News & Media
Nascent Biotech - Changing the Biotechnology Industry
Nascent Biotech - Changing the Biotechnology IndustryNASCENT BIOTECH INC. : MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF ...
OVERVIEW The following discussion should be read in conjunction with our audited financial statements and the related notes for the years ended March 31, 2021 and March 31, 2020 that appear elsewhere... | July 8, 2021Nascent Biotech Officers Convert Liability to Stock in the Company
SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTC: NBIO) Announced today that its Senior Officers have converted the Company’s liability to them into common stock, reducing the liabilities of the Company by over $1.1 million.Nascent Biotech Appoints Chief Medical Consultant in Charge of COVID-19 Research
SAN DIEGO, June 24, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTC: NBIO) announced today that it has appointed Dr. Navpaul Singh MD as Chief Medical Consultant in charge of research into Pritumumab’s use with viral infections, including COVID-19.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nascent Biotech Inc
Sign Up For FreeTo access detailed company insights
Nascent Biotech specializes in developing human antibody products for cancer treatment, notably their proprietary monoclonal antibody Pritimumab, which targets a novel antigen on cancer cells. The company has achieved FDA orphan drug status for Pritimumab, demonstrating its commitment to addressing rare forms of cancer. Their product line also incl... Read More
